SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-23-075157
Filing Date
2023-09-08
Accepted
2023-09-08 06:07:11
Documents
2
Group Members
PURCHASE CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea184910-13ga2singer_eterna.htm SC 13G/A 69962
2 JOINT FILING AGREEMENT ea184910ex99-1_eterna.htm EX-99.1 3308
  Complete submission text file 0001213900-23-075157.txt   74897
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42217 | Film No.: 231243639
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1395 BRICKELL AVENUE SUITE 800 MIAMI FL 33131
Business Address
Singer Nicholas Jason (Filed by) CIK: 0001828224 (see all company filings)

Type: SC 13G/A